Pancreatic Cancer Research

ResearcherKyushu UniversityNo recent work listed

Nanae Harashima

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5071279215. Sources: OpenAlex.

Their work

Papers
4 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 2 papers · 2016: none · 2017: 1 paper

Papers 4

  1. HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression. Co-author DOI 10.18632/oncotarget.17157↗
  2. The Roles of ROS and Caspases in TRAIL-Induced Apoptosis and Necroptosis in Human Pancreatic Cancer Cells. First author DOI 10.1371/journal.pone.0127386↗
  3. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL. First author DOI 10.18632/oncotarget.5881↗
  4. The HSP70 and autophagy inhibitor pifithrin-μ enhances the antitumor effects of TRAIL on human pancreatic cancer. First author DOI 10.1158/1535-7163.mct-12-0954↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mamoru Harada · 4 shared papers, 2013–2017 · strength 0.28
  2. Yoshitsugu Tajima · 2 shared papers, 2013–2015 · strength 0.12
  3. Keizo Takenaga · 1 shared paper, 2017 · strength 0.10
  4. Miho Akimoto · 1 shared paper, 2017 · strength 0.10
  5. Yoko Hari · 1 shared paper, 2015 · strength 0.07
  6. Min Zhang · 1 shared paper, 2015 · strength 0.06
  7. Hiroyuki Monma · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.